Tag Archives: Binimetinib
Array Biopharma, Inc. [NASDAQ: ARRY]
Federman & Sherwood Announces the Filing of a Securities Class Action Lawsuit against Array Biopharma, Inc. Oklahoma City, OK (November 22, 2017) – On November 20, 2017, a securities class action lawsuit was filed in the United States District Court for the District of Colorado against Array Biopharma, Inc. (NASDAQ: ARRY). The complaint alleges… Read More »